查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1392064

天花治疗市场：依治疗类型、给药途径、配销通路和地区分类

Smallpox Treatment Market, By Treatment Type, By Route of Administration (Oral, Injectable, Others ), By Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies), By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年全球天花治疗市场规模为6,750万美元，预计2030年将达7,800万美元，2023年至2030年复合年增长率为2.1%。

报告范围 报告详情
基准年 2022年 2023年市场规模 6750万美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 2.10% 2030年市场规模预测 7800万美元
图 1. 2023 年按地区分類的天花治疗全球市场占有率(%)
天花治疗市场-IMG1

天花是由正痘病毒科巴博拉病毒引起的一种急性传染病。天花无法治疗方法，但在接触病毒后四天内接种疫苗可以预防感染疾病的发展。目前还没有针对天花的特异性治疗方法，但正在研究开发可以杀死病毒的药物。

市场动态：

天花负担的增加、对安全有效治疗的需求不断增加、对安全有效疫苗市场开拓的日益关注以及政府的有利倡议正在推动全球天花治疗市场的增长，这些是预计推动全球天花治疗市场增长的主要因素。

例如，2021年6月，美国食品药物管理局（FDA）核准美国生物製药公司Chimerix Inc.生产的brincidofovir（BCV，Tembexa）用于治疗天花。 FDA 已根据动物规则核准了Tembexa。当人体功效研究不可行或在伦理上不可行时，该法规允许根据适当且控制良好的动物功效研究的结果进行核准。

本研究的主要特点

  • 该报告对全球天花治疗市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和复合年增长率。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据以下参数（例如公司亮点、产品系列、主要亮点、财务实绩和策略）介绍了全球天花治疗市场的主要企业。
  • 该报告的见解将使行销人员和经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略负责人资讯的决策。
  • 全球天花治疗市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球天花治疗市场的各种策略矩阵，将有助于相关人员做出决策。

目录：

第一章 研究目的与前提

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 扩大政府对抗病毒药物研究的资助和配合措施
    • 天花意识和教育
    • 老年人口增加。
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 流行病学
  • 併购场景

第四章天花治疗市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章 天花治疗市场，依治疗类型，2018-2030

  • 抗病毒药物
  • 疫苗接种
  • 支持性护理

第六章 天花治疗市场，依给药途径，2018-2030

  • 口服
  • 注射
  • 其他（外用等）

第 7 章 天花治疗市场，依配销通路划分，2018-2030

  • 医院
  • 公共
  • 私人的
  • 零售药房
  • 线上药房

第八章天花治疗市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章竞争形势

  • SIGA Technologies, Inc.
  • Bavarian Nordic A/S
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Sanofi
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Bharat Biotech International Ltd.
  • Chimerix, Inc.

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5800

The global smallpox treatment market size was valued at US$ 67.5 million in 2023 and is expected to reach US$ 78 million by 2030, grow at a compound annual growth rate (CAGR) of 2.1% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 67.5 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 2.10% 2030 Value Projection: US$ 78 Mn
Figure 1. Global Smallpox Treatment Market Share (%), by Region, 2023
Smallpox Treatment Market - IMG1

Smallpox is an acute contagious disease caused by the variola virus, a member of the orthopoxvirus family. There is no cure for smallpox, but vaccination can be used effectively to prevent infection from developing if given during a period of up to four days after a person has been exposed to the virus. There is no known specific treatment for smallpox, although research is being carried out in an attempt to create a medication capable of killing the virus.

Market Dynamics:

A rise in the burden of smallpox, growing demand for safe and effective treatment, a rise in focus on the development of safe and effective vaccines, and favorable government initiatives are major factors expected to propel the growth of the global smallpox treatment market.

For instance, in June 2021, the U.S. Food and Drug Administration (FDA) approved brincidofovir (BCV, Tembexa,) which is manufactured by Chimerix Inc., a U.S.-based biopharmaceutical company, to treat smallpox. The FDA approved Tembexa under the agency's Animal Rule, which allows findings from adequate and well-controlled animal efficacy studies to serve as the basis of approval when it is not feasible or ethical to conduct efficacy trials in humans.

Key features of the study:

  • This report provides in-depth analysis of the global smallpox treatment market, and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global smallpox treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include SIGA Technologies, Inc., Bavarian Nordic A/S, Emergent BioSolutions Inc., GlaxoSmithKline plc, Sanofi, Merck & Co., Inc., Pfizer Inc., Bharat Biotech International Ltd. and Chimerix, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global smallpox treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smallpox treatment market.

Detailed Segmentation:

  • By Treatment Type:
    • Antiviral Drugs
    • Vaccination
    • Supportive Care
  • By Route of Administration:
    • Oral
    • Injectable
    • Others (Topical, etc.)
  • By Distribution Channel:
    • Hospitals
    • Public
    • Private
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • SIGA Technologies, Inc.
    • Bavarian Nordic A/S
    • Emergent BioSolutions Inc.
    • GlaxoSmithKline plc
    • Sanofi
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Bharat Biotech International Ltd.
    • Chimerix, Inc.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Smallpox Treatment, By Treatment Type
    • Market Smallpox Treatment, By Route of Administration
    • Market Smallpox Treatment, By Distribution Channel
    • Market Smallpox Treatment, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing government funding and initiatives for research of antiviral medication
    • Awareness and education about smallpox
    • Rising geriatric population.
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Epidemiology
  • Merger and Acquisition Scenario

4. Smallpox Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Smallpox Treatment Market, By Treatment Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Antiviral Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Vaccination
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Supportive Care
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Smallpox Treatment Market, By Route of Administration, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Others (Topical, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Smallpox Treatment Market, By Distribution Channel, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Public
  • Private
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Smallpox Treatment Market, By Region, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • SIGA Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bavarian Nordic A/S
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Emergent BioSolutions Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bharat Biotech International Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Chimerix, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us